The Company incurs costs associated with restructuring initiatives intended to improve overall operating performance and profitability. The costs related to restructuring actions are generally cash-based and primarily consist of employee-related costs, which include severance and other one-time termination benefits.

In addition to the employee-related costs, the Company records other costs associated with restructuring actions, such as the gain or loss on the sale of facilities and impairment costs arising from unutilized real estate or equipment. The Company attempts to sell or lease this unutilized space, but additional impairment charges may be incurred related to these or other excess assets.

The Company’s net pretax restructuring activity included in restructuring costs, net on the Condensed Consolidated Statements of Operations, by segment, was as follows:


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2026		2025		2026		2025
Aurora		6.9		0.5		12.0		8.9
Corporate and other (1)		1.5		1.1		3.1		2.6
Total	$	8.4	$	1.6	$	15.1	$	11.5

(1)

The corporate and other line item above reflects general corporate restructuring costs that were previously allocated to the RUCKUS segment, CCS segment, OWN segment and DAS business unit. Beginning in the first quarter of 2025, the corporate and other costs related to the OWN segment and DAS business unit have been reallocated to the Company’s remaining segments and partially offset by income from the Amphenol TSA. The corporate and other costs related to the CCS segment have been reallocated to the Company’s remaining segments and partially offset by income from the Amphenol TSA beginning in the first quarter of 2026. Beginning in the third quarter of 2026, the corporate and other costs related to the RUCKUS segment will be reallocated to the Company's remaining segment and partially offset by income from the Belden TSA.

Restructuring liabilities were included in the Company’s Condensed Consolidated Balance Sheets as follows:


	June 30, 2026		December 31, 2025
Accrued and other liabilities	$	7.5	$	2.3
Other noncurrent liabilities		—		—
Total restructuring liabilities	$	7.5	$	2.3

During 2025, the Company substantially completed a restructuring program that was initiated in prior periods. As of December 31, 2025, the Company had accrued liabilities of $2.3 million related to this program, consisting of employee-related costs. These remaining obligations are expected to be settled in 2027.

Following the divestiture of the CCS segment that was completed on January 9, 2026, the Company initiated a new restructuring plan to right-size its cost structure and align operations with its revised business scope.

The following table presents activity in the Company’s accrued restructuring liabilities for the periods presented. The roll forward reflects a combined presentation of the remaining liabilities associated with the prior restructuring program and liabilities recognized under restructuring plans initiated in 2026:


	Employee-Related Costs			Other			Total
Balance at March 31, 2026	$	3.7		$	—		$	3.7
Additional expense, net		8.0			0.4			8.4
Cash paid		(4.2	)		(0.4	)		(4.6	)
Foreign exchange and other non-cash items		—			—			—
Balance at June 30, 2026	$	7.5		$	—		$	7.5

Balance at December 31, 2025	$	2.3		$	—		$	2.3
Additional expense, net		14.6			0.5			15.1
Cash paid		(9.4	)		(0.5	)		(9.9	)
Foreign exchange and other non-cash items		—			—			—
Balance at June 30, 2026	$	7.5		$	—		$	7.5